Effect of Relative Humidity on Bipolar Electrostatic Charge Profiles of dry Powder Aerosols. 2017

Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
Advanced Drug Delivery Group, Faculty of Pharmacy, The University of Sydney, NSW, 2006, Australia.

OBJECTIVE This work investigated the effect of relative humidity (RH) on bipolar electrostatic charge profiles of dry powder inhaler aerosols using the Bipolar Charge Analyzer (BOLAR). METHODS Two commercial products, Pulmicort® (400 μg, budesonide) and Bricanyl® (500 μg, terbutaline sulfate) Turbuhaler®, were used as model dry powder inhalers (DPIs) in this study. Three individual doses from each Turbuhaler® were sampled at 15, 40, 65 and 90% RH. Subsequently, charge and mass profiles were determined for each dispersion. RESULTS The aerosols from these two Turbuhaler® DPI were bipolarly charged, with larger particles carrying negative charge and smaller particles positive charge. Particles changed polarity around 2.60-4.17 μm and 0.95-2.60 μm for Pulmicort® and Bricanyl®, respectively. The effect of RH on particles differed between DPIs even though the mass output was not significantly affected. The net charge profiles of Pulmicort® were relatively independent of RH, whereas those of Bricanyl® showed a reduction in the charge magnitude with increasing RH. Both positive and negative charge profiles followed a similar trend with the change in RH and individually they had higher magnitudes than the measured net charge. CONCLUSIONS This study showed drug-specific bipolar charging of the Turbuhaler® DPI aerosols at varied RHs. Bricanyl® was more susceptible to RH and showed decreased bipolar and net charge levels with increasing RH, in comparison to Pulmicort®.

UI MeSH Term Description Entries
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006813 Humidity A measure of the amount of WATER VAPOR in the air. Humidities
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D013726 Terbutaline A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. Arubendol,Asthmoprotect,Brethaire,Brethine,Bricanyl,Bricanyl SA,Butaliret,Butalitab,Contimit,KWD-2019,Monovent,Taziken,Tedipulmo,Terbasmin,Terbul,Terbutalin AL,Terbutalin Stada,Terbutalin-ratiopharm,Terbutaline Sulfate,Terbuturmant,terbutalin von ct,KWD 2019,KWD2019,Terbutalin ratiopharm
D055672 Static Electricity The accumulation of an electric charge on a object Electrostatic,Electrostatics,Static Charge,Charge, Static,Charges, Static,Electricity, Static,Static Charges
D058995 Dry Powder Inhalers A device that delivers medication to the lungs in the form of a dry powder. Dry Powder Inhaler,Inhaler, Dry Powder,Inhalers, Dry Powder,Powder Inhaler, Dry,Powder Inhalers, Dry
D019819 Budesonide A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS. Tarpeyo,Budesonide, (R)-Isomer,Budesonide, (S)-Isomer,Horacort,Pulmicort,Rhinocort

Related Publications

Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
February 2008, Pharmaceutical research,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
September 2007, Drug development and industrial pharmacy,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
May 2007, Pharmaceutical research,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
March 1980, Journal of pharmaceutical sciences,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
January 2001, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
April 1971, Applied microbiology,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
July 2014, Pharmaceutical research,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
September 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
May 1980, The Journal of infectious diseases,
Jiaqi Yu, and Jennifer Wong, and Ari Ukkonen, and Jonna Kannosto, and Hak-Kim Chan
October 2002, International journal of pharmaceutics,
Copied contents to your clipboard!